Francisca Stutzin Donoso

Dr. Francisca Stutzin Donoso

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2018 in Globalization and Health
Verified
Journal Article
Open access
PDF file
NMNiina Markkula
Niina Markkula
Baltica CabiesesBaltica Cabieses
Baltica Cabieses
VLVenla Lehti
Venla Lehti
EUEleonora Uphoff
Eleonora Uphoff
SASofia Astorga
Sofia Astorga
FDFrancisca Stutzin Donoso
Francisca Stutzin Donoso
Migrant children have specific health needs, and may face difficulties in accessing health care, but not enough is known about their health service use. This study aims to describe patterns of use of health services of international migrant children and differences to respective native populations. Electronic databases PubMed and Web of Science, references of identified publications, and websites of relevant international agencies were searched. We included observational studies published between 2006 and 2016 that reported use of formal health services by migrant children (0–18 years), including first and second generation migrants. Data on study characteristics, study theme, main outcome and study quality were extracted. One hundred seven full texts were included in the review. Of the studies that reported comparable outcomes, half (50%) indicated less use of healthcare by migrants compared with non-migrants; 25% reported no difference, 18% reported greater use, and 7% did not report this outcome. There was variation by theme, so that the proportion of conclusions “less use” was most common in the categories “general access to care”, “primary care” and “oral health”, whereas in the use of emergency rooms or hospitalisations, the most common conclusion was “greater use”. Migrant children appear to use different types of healthcare services less than native populations, with the exception of emergency and hospital services. PROSPERO systematic review registration number: CRD42016039876 .

31 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SAStephanie Archer
Stephanie Archer
Nichola FennellNichola Fennell
Nichola Fennell
ECEllen Colvin
Ellen Colvin
RLRozelle Laquindanum
Rozelle Laquindanum
MMMeredith Mills
Meredith Mills
MTMarc Tischkowitz
Marc Tischkowitz
Women who test positive for an inherited pathogenic/likely pathogenic gene variant in BRCA1, BRCA2, PALB2, CHEK2 and ATM are at an increased risk of developing certain types of cancer—specifically breast (all) and epithelial ovarian cancer (only BRCA1, BRCA2, PALB2). Women receive broad cancer risk figures that are not personalised (e.g., 44–63% lifetime risk of breast cancer for those with PALB2). Broad, non-personalised risk estimates may be problematic for women when they are considering how to manage their risk. Multifactorial-risk-prediction tools have the potential to deliver personalised risk estimates. These may be useful in the patient’s decision-making process and impact uptake of risk-management options. This randomised control trial (registration number to follow), based in genetic centres in the UK and US, will randomise participants on a 1:1 basis to either receive conventional cancer risk estimates, as per routine clinical practice, or to receive a personalised risk estimate. This personalised risk estimate will be calculated using the CanRisk risk prediction tool, which combines the patient’s genetic result, family history and polygenic risk score (PRS), along with hormonal and lifestyle factors. Women’s decision-making around risk management will be monitored using questionnaires, completed at baseline (pre-appointment) and follow-up (one, three and twelve months after receiving their risk assessment). The primary outcome for this study is the type and timing of risk management options (surveillance, chemoprevention, surgery) taken up over the course of the study (i.e., 12 months). The type of risk-management options planned to be taken up in the future (i.e., beyond the end of the study) and the potential impact of personalised risk estimates on women’s psychosocial health will be collected as secondary-outcome measures. This study will also assess the acceptability, feasibility and cost-effectiveness of using personalised risk estimates in clinical care.

12 April 2023 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
SAStephanie Archer
Stephanie Archer
FDFrancisca Stutzin Donoso
Francisca Stutzin Donoso
TCTim Carver
Tim Carver
AYAdelaide Yue
Adelaide Yue
ACAlex P Cunningham
Alex P Cunningham
FWFiona M Walter
Fiona M Walter
Background: The CanRisk tool enables the collection of risk factor information and calculation of estimated future breast cancer risks based on the multifactorial Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) model. Despite BOADICEA being recommended in National Institute for Health and Care Excellence (NICE) guidelines and CanRisk being freely available for use, the CanRisk tool has not yet been widely implemented in primary care.Aim: To explore the barriers to and facilitators of the implementation of the CanRisk tool in primary care.Design and setting: A multi-methods study was conducted with primary care practitioners (PCPs) in the East of England.Method: Participants used the CanRisk tool to complete two vignette-based case studies; semi-structured interviews gained feedback about the tool; and questionnaires collected demographic details and information about the structural characteristics of the practices.Results: Sixteen PCPs (eight GPs and eight nurses) completed the study. The main barriers to implementation included: time needed to complete the tool; competing priorities; IT infrastructure; and PCPs’ lack of confidence and knowledge to use the tool. Main facilitators included: easy navigation of the tool; its potential clinical impact; and the increasing availability of and expectation to use risk prediction tools.Conclusion: There is now a greater understanding of the barriers and facilitators that exist when using CanRisk in primary care. The study has highlighted that future implementation activities should focus on reducing the time needed to complete a CanRisk calculation, integrating the CanRisk tool into existing IT infrastructure, and identifying appropriate contexts in which to conduct a CanRisk calculation. PCPs may also benefit from information about cancer risk assessment and CanRisk-specific training.

22 August 2024 in Public Health Ethics
Verified
Journal Article
Open access
PDF file
FDFrancisca Stutzin Donoso
Francisca Stutzin Donoso
Much of the academic literature on chronic disease argues that failure to adjust to chronic disease is strongly associated with poor self-management (SM)—mainly understood as adherence to long-term treatment 1, so there is a strong focus on self-management support (SMS) in chronic care ( Bodenheimer et al., 2002; Ridder et al., 2008).A comprehensive review from 2003 conducted by experts from the World Health Organization (WHO) reported that adherence to long-term treatments was around 50 per cent in high-income countries and presumably comparable or lower in low-and-middle income countries, contributing to the high rates of premature death and poor individual and population health outcomes ( Sabaté, 2003). Even though this report has not been updated, recent systematic reviews about this issue continue to report sub-optimal adherence worldwide, adding a possible social gradient in long-term treatment adherence ( Ortego et al., 2011; Gast and Mathes, 2019; Ogungbe et al., 2021).

4 August 2020 in Medical Humanities
Verified
Journal Article
Open access
PDF file
FDFrancisca Stutzin Donoso
Francisca Stutzin Donoso
In light of the large burden of chronic disease and the low rates of long-term treatment adherence contributing to high rates of morbidity and mortality worldwide, this paper contributes to better understanding the particular kind of challenge that living with chronic illness and adhering to long-term treatment can imply. Both literature on the concept of chronic disease and the experience of illness suggest going outside specific diagnostic categories to better understand the problem of adherence. After introducing the distinction of a thin understanding of chronicity—merely as long duration—and a thick one—chronicity in a phenomenological sense, this paper analyses academic literature on the experience of illness and specifies it to the case of chronic diseases, introducing an original conceptual framework describing some main challenges arising from the experience of chronic disease. The framework is organised in three dimensions: failing to recover as a failure to belong, being at a loss and breaking-up with oneself. This work suggests a particular subjective state in which struggling to follow long-term treatment may seem understandable and reasonable, offering a phenomenological perspective that feeds into the ethical problems arising in chronic diseases, and shedding light on how to increase adherence without reproducing patterns of disadvantage.

5 May 2022 in Journal of Medical Ethics
Verified
Journal Article
Closed access
PDF file
FDFrancisca Stutzin Donoso
Francisca Stutzin Donoso